You have free access to this content

British Journal of Clinical Pharmacology

Cover image for Vol. 60 Issue 2

August 2005

Volume 60, Issue 2

Pages 117–227

  1. Editors’ view

    1. Top of page
    2. Editors’ view
    3. Pharmacodynamics
    4. Pharmacokinetics and Pharmacodynamics
    5. Pharmacoepidemiology
    6. Pharmacogenetics
    7. Drug disposition
    8. Therapeutics
    9. Adverse drug effects
    10. Drug interactions
    11. Short Reports
    12. Letter to the Editors
    13. Book Review
    1. You have free access to this content
      Metameta-analysis (pages 117–119)

      J. K. Aronson

      Version of Record online: 24 JUL 2005 | DOI: 10.1111/j.1365-2125.2005.02482.x

  2. Pharmacodynamics

    1. Top of page
    2. Editors’ view
    3. Pharmacodynamics
    4. Pharmacokinetics and Pharmacodynamics
    5. Pharmacoepidemiology
    6. Pharmacogenetics
    7. Drug disposition
    8. Therapeutics
    9. Adverse drug effects
    10. Drug interactions
    11. Short Reports
    12. Letter to the Editors
    13. Book Review
    1. You have free access to this content
      Assessment of the effect of a single oral dose of telithromycin on sotalol-induced qt interval prolongation in healthy women (pages 120–127)

      Jean-Louis Démolis, Soraya Strabach, Françoise Vacheron and Christian Funck-Brentano

      Version of Record online: 30 MAR 2005 | DOI: 10.1111/j.1365-2125.2005.02395.x

      • image
      • image
  3. Pharmacokinetics and Pharmacodynamics

    1. Top of page
    2. Editors’ view
    3. Pharmacodynamics
    4. Pharmacokinetics and Pharmacodynamics
    5. Pharmacoepidemiology
    6. Pharmacogenetics
    7. Drug disposition
    8. Therapeutics
    9. Adverse drug effects
    10. Drug interactions
    11. Short Reports
    12. Letter to the Editors
    13. Book Review
    1. You have free access to this content
      The central nervous system effects, pharmacokinetics and safety of the NAALADase-inhibitor GPI 5693 (pages 128–136)

      J. P. Van Der Post, S. J. De Visser, M. L. De Kam, M. Woelfler, D. C. Hilt, J. Vornov, E. S. Burak, E. Bortey, B. S. Slusher, T. Limsakun, A. F. Cohen and J. M. A. Van Gerven

      Version of Record online: 31 MAY 2005 | DOI: 10.1111/j.1365-2125.2005.02396.x

      • image
      • image
      • image
      • image
      • image
  4. Pharmacoepidemiology

    1. Top of page
    2. Editors’ view
    3. Pharmacodynamics
    4. Pharmacokinetics and Pharmacodynamics
    5. Pharmacoepidemiology
    6. Pharmacogenetics
    7. Drug disposition
    8. Therapeutics
    9. Adverse drug effects
    10. Drug interactions
    11. Short Reports
    12. Letter to the Editors
    13. Book Review
    1. You have free access to this content
      Inappropriate drug prescribing in older adults: the updated 2002 Beers criteria – a population-based cohort study (pages 137–144)

      Cornelis S. Van Der Hooft, Geert W.’t Jong, Jeanne P. Dieleman, Katia M. C. Verhamme, Tischa J. M. Van Der Cammen, Bruno H. CH. Stricker and Miriam C. J. M. Sturkenboom

      Version of Record online: 30 MAR 2005 | DOI: 10.1111/j.1365-2125.2005.02391.x

      • image
    2. You have free access to this content
      Off-label prescribing to children: attitudes and experience of general practitioners (pages 145–149)

      Suzie Ekins-Daukes, Peter J. Helms, Michael W. Taylor and James S. McLay

      Version of Record online: 30 MAR 2005 | DOI: 10.1111/j.1365-2125.2005.02397.x

      • image
      • image
      • image
    3. You have free access to this content
      Statin use after acute myocardial infarction: a nationwide study in Denmark (pages 150–158)

      Jeppe N. Rasmussen, Gunnar H. Gislason, Steen Z. Abildstrom, Søren Rasmussen, Ida Gustafsson, Pernille Buch, Jens Friberg, Lars Køber, Christian Torp-Pedersen, Mette Madsen and Steen Stender

      Version of Record online: 6 MAY 2005 | DOI: 10.1111/j.1365-2125.2005.02408.x

      • image
      • image
      • image
      • image
  5. Pharmacogenetics

    1. Top of page
    2. Editors’ view
    3. Pharmacodynamics
    4. Pharmacokinetics and Pharmacodynamics
    5. Pharmacoepidemiology
    6. Pharmacogenetics
    7. Drug disposition
    8. Therapeutics
    9. Adverse drug effects
    10. Drug interactions
    11. Short Reports
    12. Letter to the Editors
    13. Book Review
    1. You have free access to this content
      Meta-analysis of the influence of MDR1 C3435T polymorphism on digoxin pharmacokinetics and MDR1 gene expression (pages 159–171)

      Balram Chowbay, Huihua Li, Machin David, Yin Bun Cheung and Edmund J. D. Lee

      Version of Record online: 6 MAY 2005 | DOI: 10.1111/j.1365-2125.2005.02392.x

      • image
      • image
      • image
      • image
  6. Drug disposition

    1. Top of page
    2. Editors’ view
    3. Pharmacodynamics
    4. Pharmacokinetics and Pharmacodynamics
    5. Pharmacoepidemiology
    6. Pharmacogenetics
    7. Drug disposition
    8. Therapeutics
    9. Adverse drug effects
    10. Drug interactions
    11. Short Reports
    12. Letter to the Editors
    13. Book Review
    1. You have free access to this content
      Inhibition of the metabolism of brotizolam by erythromycin in humans: in vivo evidence for the involvement of CYP3A4 in brotizolam metabolism (pages 172–175)

      Takaki Tokairin, Takashi Fukasawa, Norio Yasui-Furukori, Toshiaki Aoshima, Akihito Suzuki, Yoshimasa Inoue, Tomonori Tateishi and Koichi Otani

      Version of Record online: 30 MAR 2005 | DOI: 10.1111/j.1365-2125.2005.02380.x

      • image
    2. You have free access to this content
      Kidneys contribute to the extrahepatic clearance of propofol in humans, but not lungs and brain (pages 176–182)

      Haruhiko Hiraoka, Koujirou Yamamoto, Soutarou Miyoshi, Toshihiro Morita, Katsunori Nakamura, Yuuji Kadoi, Fumio Kunimoto and Ryuya Horiuchi

      Version of Record online: 30 MAR 2005 | DOI: 10.1111/j.1365-2125.2005.02393.x

  7. Therapeutics

    1. Top of page
    2. Editors’ view
    3. Pharmacodynamics
    4. Pharmacokinetics and Pharmacodynamics
    5. Pharmacoepidemiology
    6. Pharmacogenetics
    7. Drug disposition
    8. Therapeutics
    9. Adverse drug effects
    10. Drug interactions
    11. Short Reports
    12. Letter to the Editors
    13. Book Review
    1. You have free access to this content
      Pharmaceutical care of patients with heart failure (pages 183–193)

      A. Sadik, M. Yousif and J. C. McElnay

      Version of Record online: 6 MAY 2005 | DOI: 10.1111/j.1365-2125.2005.02387.x

      • image
      • image
  8. Adverse drug effects

    1. Top of page
    2. Editors’ view
    3. Pharmacodynamics
    4. Pharmacokinetics and Pharmacodynamics
    5. Pharmacoepidemiology
    6. Pharmacogenetics
    7. Drug disposition
    8. Therapeutics
    9. Adverse drug effects
    10. Drug interactions
    11. Short Reports
    12. Letter to the Editors
    13. Book Review
    1. You have free access to this content
      Do nonsteroidal anti-inflammatory drugs affect the risk of developing ovarian cancer? A meta-analysis (pages 194–203)

      Stefanos Bonovas, Kalitsa Filioussi and Nikolaos M. Sitaras

      Version of Record online: 30 MAR 2005 | DOI: 10.1111/j.1365-2125.2005.02386.x

      • image
      • image
    2. You have free access to this content
      Angiotensin II receptor blocker-induces blunted taste sensitivity: comparison of candesartan and valsartan (pages 204–207)

      Shuichi Tsuruoka, Michi Wakaumi, Takashi Ioka, Hisashi Yamamoto, Hitoshi Ando, Kohichi Sugimoto and Akio Fujimura

      Version of Record online: 30 MAR 2005 | DOI: 10.1111/j.1365-2125.2005.02394.x

      • image
  9. Drug interactions

    1. Top of page
    2. Editors’ view
    3. Pharmacodynamics
    4. Pharmacokinetics and Pharmacodynamics
    5. Pharmacoepidemiology
    6. Pharmacogenetics
    7. Drug disposition
    8. Therapeutics
    9. Adverse drug effects
    10. Drug interactions
    11. Short Reports
    12. Letter to the Editors
    13. Book Review
    1. You have free access to this content
      Coadministration of gemfibrozil and itraconazole has only a minor effect on the pharmacokinetics of the CYP2C9 and CYP3A4 substrate nateglinide (pages 208–217)

      Mikko Niemi, Janne T. Backman, Laura Juntti-Patinen, Mikko Neuvonen and Pertti J. Neuvonen

      Version of Record online: 30 MAR 2005 | DOI: 10.1111/j.1365-2125.2005.02385.x

      • image
      • image
      • image
      • image
      • image
  10. Short Reports

    1. Top of page
    2. Editors’ view
    3. Pharmacodynamics
    4. Pharmacokinetics and Pharmacodynamics
    5. Pharmacoepidemiology
    6. Pharmacogenetics
    7. Drug disposition
    8. Therapeutics
    9. Adverse drug effects
    10. Drug interactions
    11. Short Reports
    12. Letter to the Editors
    13. Book Review
    1. You have free access to this content
      Profound weight loss associated with reboxetine use in a 44-year-old woman (pages 218–220)

      T. Y.-T. Lu, A. Kupa, G. Easterbrook and A. A. Mangoni

      Version of Record online: 6 MAY 2005 | DOI: 10.1111/j.1365-2125.2005.02407.x

      • image
    2. You have free access to this content
      A distance-learning programme in pharmacovigilance linked to educational credits is associated with improved reporting of suspected adverse drug reactions via the UK yellow card scheme (pages 221–223)

      Robert C. G. Bracchi, Jane Houghton, Fiona J. Woods, Simon Thomas, Simon A. Smail and Philip A. Routledge

      Version of Record online: 6 MAY 2005 | DOI: 10.1111/j.1365-2125.2005.02419.x

  11. Letter to the Editors

    1. Top of page
    2. Editors’ view
    3. Pharmacodynamics
    4. Pharmacokinetics and Pharmacodynamics
    5. Pharmacoepidemiology
    6. Pharmacogenetics
    7. Drug disposition
    8. Therapeutics
    9. Adverse drug effects
    10. Drug interactions
    11. Short Reports
    12. Letter to the Editors
    13. Book Review
    1. You have free access to this content
      Effect of pregnancy on a measure of FMO3 activity (pages 224–226)

      Janne Hukkanen, Delia Dempsey, Peyton Jacob III and Neal L. Benowitz

      Version of Record online: 6 MAY 2005 | DOI: 10.1111/j.1365-2125.2005.02406.x

  12. Book Review

    1. Top of page
    2. Editors’ view
    3. Pharmacodynamics
    4. Pharmacokinetics and Pharmacodynamics
    5. Pharmacoepidemiology
    6. Pharmacogenetics
    7. Drug disposition
    8. Therapeutics
    9. Adverse drug effects
    10. Drug interactions
    11. Short Reports
    12. Letter to the Editors
    13. Book Review
    1. You have free access to this content
      Cardiac safety of noncardiac drugs (page 227)

      S. H. L. Thomas

      Version of Record online: 6 MAY 2005 | DOI: 10.1111/j.1365-2125.2005.02412.x

SEARCH

SEARCH BY CITATION